BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10354131)

  • 1. P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study.
    Dhooge C; De Moerloose B; Laureys G; Kint J; Ferster A; De Bacquer D; Philippe J; Benoit Y
    Br J Haematol; 1999 Jun; 105(3):676-83. PubMed ID: 10354131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of P-glycoprotein (P-gp) expression in childhood acute lymphoblastic leukemia. Results of a 6-year prospective study.
    Dhooge C; De Moerloose B
    Adv Exp Med Biol; 1999; 457():11-9. PubMed ID: 10500775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: results of a long-term prospective study.
    Dhooge C; De Moerloose B; Laureys G; Ferster A; De Bacquer D; Philippe J; Leroy J; Benoit Y
    Leuk Lymphoma; 2002 Feb; 43(2):309-14. PubMed ID: 11999562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia.
    Casale F; D'Angelo V; Addeo R; Caraglia M; Crisci S; Rondelli R; Di Tullio MT; Indolfi P
    Oncol Rep; 2004 Dec; 12(6):1201-7. PubMed ID: 15547738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia.
    Damiani D; Michelutti A; Michieli M; Masolini P; Stocchi R; Geromin A; Ermacora A; Russo D; Fanin R; Baccarani M
    Br J Haematol; 2002 Mar; 116(3):519-27. PubMed ID: 11849207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
    Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children.
    Plasschaert SL; Vellenga E; de Bont ES; van der Kolk DM; Veerman AJ; Sluiter WJ; Daenen SM; de Vries EG; Kamps WA
    Leuk Lymphoma; 2003 Jan; 44(1):85-95. PubMed ID: 12691146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of expression and functional activity of P-GP membrane glycoprotein in children with acute leukemia.
    Shman TV; Savitskii VP; Potapnev MP; Aleinikova OV
    Bull Exp Biol Med; 2006 Jun; 141(6):727-30. PubMed ID: 17364061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
    Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
    Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the MDR1 gene product P-glycoprotein in childhood neuroblastoma.
    Dhooge CR; De Moerloose BM; Benoit YC; Van Roy N; Philippé ; Laureys GG
    Cancer; 1997 Oct; 80(7):1250-7. PubMed ID: 9317175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up.
    Kanerva J; Tiirikainen MI; Mäkipernaa A; Riikonen P; Möttönen M; Salmi TT; Krusius T; Saarinen-Pihkala UM
    Pediatr Hematol Oncol; 2001; 18(1):27-36. PubMed ID: 11205837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDR1/P-GP expression as a prognostic factor in acute leukemias.
    Marie JP; Legrand O
    Adv Exp Med Biol; 1999; 457():1-9. PubMed ID: 10500774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications.
    Goasguen JE; Dossot JM; Fardel O; Le Mee F; Le Gall E; Leblay R; LePrise PY; Chaperon J; Fauchet R
    Blood; 1993 May; 81(9):2394-8. PubMed ID: 8097634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia.
    Tafuri A; Sommaggio A; Burba L; Albergoni MP; Petrucci MT; Mascolo MG; Testi AM; Basso G
    Leuk Res; 1995 Dec; 19(12):927-31. PubMed ID: 8632662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-gp expression and Rh 123 efflux assay have no impact on survival in Egyptian pediatric acute lymphoblastic leukemia patients.
    Kamel AM; El-Sharkawy N; Yassin D; Shaaban K; Hussein H; Sidhom I; Abo El-Naga S; Ameen M; El-Hattab O; Aly El-Din NH
    J Egypt Natl Canc Inst; 2005 Sep; 17(3):165-72. PubMed ID: 16799654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
    Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
    Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALL.
    Kanerva J; Tiirikainen M; Mäkipernaa A; Riikonen P; Möttönen M; Salmi TT; Krusius T; Saarinen-Pihkala UM
    Pediatr Hematol Oncol; 1998; 15(1):11-21. PubMed ID: 9509502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
    Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
    J Clin Oncol; 1996 Oct; 14(10):2812-7. PubMed ID: 8874343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
    Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig WD
    Br J Haematol; 2000 Jul; 110(1):154-60. PubMed ID: 10930993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
    Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.